Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Increased Hemodialysis Improves Survival Rates

By HospiMedica staff writers
Posted on 01 Dec 2006
A new study has found that more-frequent hemodialysis treatments can significantly increase the survival rate of patients suffering from irreversible kidney failure.

Researchers from the University of Washington (Seattle, USA) and Northwest Kidney Centers (Seattle, WA, USA) compared survival rates in 117 patients treated by short-daily hemodialysis in 2003 and 2004 with patients reported in the 2003 data from the United States Renal Data System (USRDS). More...
Expected mortality was calculated from the USRDS and compared with observed actual mortality. The standardized mortality ratio (SMR) was used to adjust for differences in patient age, sex, race, and cause of renal failure.

The SMR for the short-daily hemodialysis patients was found to be 0.39, statistically significantly better than data from the overall U.S. population of hemodialysis patients, indicating that daily hemodialysis patients had a 61% better survival than regular hemodialysis patients. The study was published in the October 2006 issue of Hemodialysis International.

"More frequent hemodialysis has been shown to improve patient well-being, reduce symptoms during and between treatments, and have beneficial effects on clinical outcomes,” said lead author Christopher R. Blagg M.D., of Northwest Kidney Centers.

During regular hemodialysis, the patient spends around six hours two to three times a week connected to a dialysis machine. The dialysis machine filters out unwanted wastes from a continuous flow of blood through a semipermeable membrane that is immersed in a special dialysis solution. Frequent hemodialysis involves treatment five or more times a week.



Related Links:
University of Washington
Northwest Kidney Centers

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.